Food ingredient compliance in the United States could undergo a significant change following the FDA's proposed Generally Recognized as Safe (GRAS) rule announced on August 10, 2026. The proposal would require companies to notify the agency when they determine that a substance qualifies for GRAS status under its intended conditions of use, replacing the current voluntary notification approach for uses covered by the proposed requirements.
For food ingredient manufacturers, chemical suppliers, importers and procurement teams, this development could affect how businesses document ingredient safety, introduce new products and evaluate suppliers serving the American market. Understanding the existing framework and the proposed changes can help companies prepare their regulatory documentation and make better sourcing decisions.
What GRAS Means for Food Ingredient Suppliers
GRAS stands for Generally Recognized as Safe. Under the Federal Food, Drug, and Cosmetic Act, certain substances added to food can qualify for an exemption from the standard premarket food additive approval requirements when qualified experts generally recognize their safety under the intended conditions of use.
The framework does not mean that every substance described as safe by a manufacturer automatically qualifies. Companies need an appropriate scientific basis for their conclusions, and the evidence must support the particular way they intend to use the ingredient.
For example, an ingredient may have an established history of use in one food category but require additional evidence when a manufacturer proposes a different application, concentration or exposure level. Safety assessments must consider the intended use rather than relying exclusively on the ingredient's name or its use in another formulation.
GRAS status can therefore influence product development, regulatory planning and commercial access. For suppliers, the ability to explain the scientific and regulatory basis of an ingredient's status can also support customer confidence during qualification and purchasing reviews.
How the Existing GRAS Framework Works
Under the existing framework, companies can reach a GRAS conclusion through scientific procedures or, where applicable, evidence of common use in food before January 1, 1958. Scientific procedures generally require evidence that qualified experts can evaluate, while the historical-use pathway depends on an appropriate record of food consumption.
The FDA operates a voluntary GRAS notification program. A company can submit a notice explaining why it considers a substance safe for its intended use, after which the agency evaluates the information and communicates its response.
However, companies have not generally been required to submit a GRAS notice simply because they concluded that a substance qualified for this status. This has allowed some businesses to introduce substances based on their own GRAS determinations without submitting those conclusions to the FDA's notification program.
This distinction matters for buyers. The absence of an FDA GRAS notice does not, by itself, establish that an ingredient is unsafe or that its use is unlawful. Equally, a supplier's statement that an ingredient is GRAS does not independently demonstrate that every proposed application meets the relevant safety requirements.
Procurement teams should therefore evaluate the evidence behind a supplier's claims, including the intended application, relevant specifications and supporting safety documentation.
What the FDA Proposed in August 2026
The proposed rule would change the notification process from voluntary to mandatory for covered GRAS uses, subject to specified exceptions. It would amend the regulations governing human and animal food ingredients under 21 CFR Parts 170 and 570.
The proposal aims to give the FDA greater visibility into substances entering the food supply and help the agency determine whether particular uses qualify for the GRAS exemption or instead require food additive review and approval.
Key elements include:
Mandatory notification: Companies introducing covered substances into interstate commerce under the GRAS provision would generally need to submit a notice to the FDA explaining the basis for their safety conclusion.
Greater public transparency: The FDA would maintain a public-facing inventory of relevant submissions, making information about covered substances and their intended uses easier to access.
Defined submission requirements: Companies would need to provide structured information about ingredient identity, intended use and the basis for their GRAS determination.
Limited exceptions and transition provisions: The proposal includes a time-limited streamlined submission option for certain substances already in interstate commerce, subject to eligibility and other requirements.
Clearer regulatory intervention: The FDA could identify uses that require a GRAS notice or a food additive petition rather than relying on an unsupported GRAS claim.
These changes could increase the administrative work associated with introducing ingredients to the US market. They would also give buyers and other market participants more information when evaluating the regulatory position of food ingredients.
What Information May Be Required in a GRAS Notice
The proposed notification requirements make accurate technical documentation particularly important. Businesses should expect to organize evidence that explains both what a substance is and why its intended use qualifies for GRAS status.
The proposed framework identifies several categories of information relevant to a notice:
Ingredient identity and manufacturing: A clear description of the substance, its manufacturing method, specifications and relevant technical properties.
Intended conditions of use: The food categories in which the ingredient will appear, its intended technological purpose and the proposed levels of use.
Dietary exposure: An assessment of expected exposure from the proposed use, supported by relevant consumption assumptions and calculations.
Scientific safety evidence: Data and information supporting the conclusion that the substance is safe under the specified conditions of use.
Explanation of the GRAS conclusion: A scientific narrative describing how the available evidence supports the conclusion and why qualified experts can recognize the substance's safety.
Supporting references: A list of the scientific studies, data and other relevant information used to establish the safety assessment.
Additional information may apply when a company relies on historical food use or when particular conditions make further evidence necessary. The precise submission requirements will depend on the final rule and the circumstances of the ingredient.
For ingredient developers, this means regulatory documentation should become part of product development rather than a task postponed until a customer requests supporting evidence.
Implications for Ingredient Manufacturers and Chemical Suppliers
The proposed rule could affect companies at several stages of the food ingredient supply chain. Manufacturers developing new ingredients may need to account for notification preparation, scientific review and regulatory planning when establishing launch schedules.
Suppliers of established ingredients may also face more questions from customers about their GRAS status, particularly where a product serves multiple food applications. A general statement about safety may not answer whether the evidence covers a specific use, concentration or exposure scenario.
Businesses should consider several practical priorities:
Review ingredient portfolios. Identify products sold for food applications and determine which intended uses rely on GRAS conclusions that could fall within the proposed requirements.
Strengthen technical files. Keep manufacturing descriptions, specifications, analytical results and relevant safety evidence organized and accessible.
Clarify regulatory responsibilities. Establish which party will prepare submissions, maintain supporting information and communicate with the FDA when manufacturers, distributors and importers share responsibilities.
Plan for development costs. Include scientific assessments, regulatory expertise and documentation work in project budgets where applicable.
Improve customer communication. Give buyers accurate information about the intended use and the supporting evidence available for each relevant ingredient.
Smaller ingredient developers may face a greater relative administrative burden because they have fewer dedicated regulatory resources. Early planning can help businesses identify documentation gaps before those gaps affect customer qualification or commercial launch dates.
How the Proposal Could Affect Procurement and International Trade
For importers, exporters and procurement managers, the proposal could make regulatory due diligence a more prominent part of supplier selection. A competitive price or a consistent product specification may not be sufficient when a buyer also needs evidence that an ingredient is suitable for a particular US food application.
International suppliers should pay particular attention to the distinction between general product quality and regulatory suitability. A certificate of analysis can establish whether a batch meets specified analytical parameters, but it does not necessarily demonstrate that every intended food use qualifies for GRAS status.
Procurement teams can strengthen their processes by asking suppliers to provide:
Current product specifications and certificates of analysis.
Ingredient identity and manufacturing information.
Available scientific safety assessments and supporting references.
Documentation explaining the ingredient's regulatory status for the intended application.
Information about relevant GRAS notices, FDA correspondence or other applicable regulatory authorizations.
Buyers should also distinguish between an ingredient's general commercial availability and its eligibility for a particular use in the United States. Different food applications can involve different conditions, exposure levels and regulatory requirements.
For international traders, consistent documentation can make supplier qualification more efficient and reduce the risk of unexpected delays during customer reviews. It can also help procurement teams compare suppliers on regulatory readiness rather than price alone.
Regulatory Timing and the Importance of Staying Informed
As of October 2026, the FDA's GRAS proposal remains a proposed rule rather than a final regulation. The agency is collecting public feedback, and the proposed requirements may change before the final rule takes effect.
The comment deadline is December 9, 2026. The FDA has also published information explaining the proposal and its intended approach to greater oversight of GRAS substances.
Companies should use this period to understand how the proposal could affect their ingredient portfolios and existing procedures. They should also monitor official updates rather than treating the proposed requirements as though every provision already applies.
Useful preparation steps include reviewing current GRAS assessments, identifying products with incomplete supporting documentation and assigning responsibility for tracking regulatory developments. Companies introducing new ingredients may also benefit from evaluating notification preparation within their product development timelines.
The final rule will determine the precise obligations, applicable exceptions and transition arrangements. Businesses that organize their records now will be better positioned to respond once the requirements become clearer.
What Buyers and Suppliers Should Do Next
The proposed GRAS rule highlights the importance of connecting food ingredient sourcing with scientific evidence and regulatory documentation. Manufacturers need to understand the basis of their safety conclusions, while suppliers and procurement teams need to establish whether available evidence supports the specific applications under consideration.
For procurement professionals, the immediate priority is to build a reliable picture of each ingredient's identity, intended use and supporting regulatory documentation. For ingredient developers, it is to evaluate potential notification requirements early enough to incorporate them into development plans and commercial decisions.
Businesses should also maintain clear communication between technical, quality, regulatory and purchasing teams. This coordination can help identify gaps before they affect supplier approval, product formulation or market entry.
As the FDA considers feedback on the proposal, companies that prepare their documentation and review their sourcing processes can make more informed decisions about serving the US food ingredient market. Reliable supplier records and application-specific safety evidence will remain important parts of responsible ingredient procurement.
Sodium Benzoate (E211) CAS: 532-32-1
SOURCE LINK: https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras
